AIKI

AIkido Pharma Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

AIKI price

AIkido Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AIKI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AIKI

Valuation

P/E

0.00

Sector -3.34

Industry -3.34

P/BV

0.00

Sector 1.89

Industry 1.89

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

Sector -219.22

Industry -219.22

EV/EBIT

Sector -47.87

Industry -47.87

P/EBITDA

Sector -22.33

Industry -22.33

P/EBIT

Sector -28.88

Industry -28.88

P/Total Assets

Sector 1.11

Industry 1.11

P/Net Current Assets

Sector -9.46

Industry -9.46

P/Working Capital

Sector -148.60

Industry -148.60

EPS

-3.68

Sector -1.78

Industry -1.78

BVPS

15.31

Sector 1.98

Industry 1.98

Efficiency

Gross Margin

0.00%

Sector 41.35%

Industry 41.35%

EBITDA Margin

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

0.00%

Sector -35.47%

Industry -35.47%

Net Profit Margins

0.00%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-24.03%

Sector -57.36%

Industry -57.36%

ROA

-23.29%

Sector -59.44%

Industry -59.44%

ROIC

Sector -2,371.18%

Industry -2,371.18%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.91

Industry 2.91

Net Debt / EBITDA

Sector -21.45

Industry -21.45

Net Debt / EBIT

Sector -8.32

Industry -8.32

Net Debt / Equity

Sector -33,201.77

Industry -33,201.77

Gross Debt / Equity

Sector -0.85

Industry -0.85

Equity/Assets

0.97

Sector 0.46

Industry 0.46

Liabilities/Assets

0.03

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

22.36%

Sector -

Industry -

Fundamentals AIKI

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AIKI AIkido Pharma Inc.	$0.00	-	0.00%	0.00	0.00	-24.03%	0.00%
PFE Pfizer Inc.	$28.25	23.91%	6.23%	36.34	1.84	5.07%	6.80%
ABBV AbbVie Inc.	$276.61	23.83%	2.47%	77.50	-82.49	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.20	-30.25%	4.83%	9.39	4.99	53.11%	35.32%
MRK Merck & Co. Inc.	$142.71	70.83%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$157.00	-5.51%	2.03%	19.02	4.90	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$56.36	35.67%	4.26%	12.97	5.39	41.59%	18.87%
ZTS Zoetis Inc.	$75.14	-45.73%	2.81%	11.76	9.85	83.77%	27.69%
AMGN Amgen Inc.	$414.70	46.88%	2.41%	25.51	19.08	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$750.47	35.09%	0.49%	17.80	2.43	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$109.37	70.62%	0.00%	31.72	91.40	288.13%	24.86%
MCK McKesson Corporation	$962.85	26.60%	0.36%	24.20	-28.76	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$489.96	20.15%	0.00%	29.37	6.39	21.76%	35.00%
CAH Cardinal Health Inc.	$237.45	53.30%	0.86%	32.46	-20.43	-62.92%	0.67%
ARGX argenx SE	$803.12	0.78%	0.00%	15.66	4.13	26.35%	25.62%
HRMY Harmony Biosciences Holdings Inc.	$36.74	38.43%	0.00%	12.88	2.34	18.14%	18.88%
BIIB Biogen Inc.	$228.84	56.13%	0.00%	40.08	1.77	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AIKI - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT AIkido Pharma

AIkido Pharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

59 years

Founded: 1967

1978

Time since IPO - 48 years

5

Employees

AIkido Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $81.85 million.

The company employs approximately 5 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, AIkido Pharma Inc. reported $- in revenue, generating net income of $-19.67 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AIKI.

Market cap

Net worth

$81.85 million

$81,847,000.00

Assets

$84.45 million

$84,447,000.00

Total Shares Outstanding

5.34 million

5,344,000

Average Daily Trading Volume

$33.19 Thousand

$33,185.94

Sector

Health Care

Industry

Biotechnology

AIKI

AIKI revenue and profits

Financial Results AIKI

DRAG THE FRAME TO SEE MORE DATA

AIKI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$962.85 25,62% (12M)

P/E

24.20

0.36%

ROE

-118.84%

P/BV

-28.76

CAH - Cardinal Health

$237.45 55,85% (12M)

P/E

32.46

0.86%

ROE

-62.92%

P/BV

-20.43

ABBV - AbbVie

$276.61 23,94% (12M)

P/E

77.50

2.47%

ROE

-106.44%

P/BV

-82.49

MRK - Merck & Co.

$142.71 71,41% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$157.00 --6,19% (12M)

P/E

19.02

2.03%

ROE

25.77%

P/BV

4.90

PFE - Pfizer

$28.25 24,16% (12M)

P/E

36.34

6.23%

ROE

5.07%

P/BV

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12M)

P/E

12.97

4.26%

ROE

41.59%

P/BV

5.39

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$962.85 25,62% (12 M)

P/L

24.20

0.36%

ROE

-118.84%

P/VP

-28.76

CAH - Cardinal Health

$237.45 55,85% (12 M)

P/L

32.46

0.86%

ROE

-62.92%

P/VP

-20.43

ABBV - AbbVie

$276.61 23,94% (12 M)

P/L

77.50

2.47%

ROE

-106.44%

P/VP

-82.49

MRK - Merck & Co.

$142.71 71,41% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$157.00 --6,19% (12 M)

P/L

19.02

2.03%

ROE

25.77%

P/VP

4.90

PFE - Pfizer

$28.25 24,16% (12 M)

P/L

36.34

6.23%

ROE

5.07%

P/VP

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12 M)

P/L

12.97

4.26%

ROE

41.59%

P/VP

5.39

Frequently Asked Questions

What is the price of AIkido Pharma (AIKI) today?

The current price of AIkido Pharma (AIKI) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does AIkido Pharma (AIKI) pay dividends?

AIkido Pharma (AIKI) did not pay dividends over the past year.

Is AIkido Pharma (AIKI) a good investment?

AIkido Pharma (AIKI) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a -177% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy AIkido Pharma (AIKI) stock?

You can buy AIkido Pharma (AIKI) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol AIKI and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of AIkido Pharma (AIKI) yield today?

Over the past month, AIkido Pharma (AIKI) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of AIkido Pharma (AIKI) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AIKI

AIkido Pharma Inc.

Asset unavailable for trading

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AIKI

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING AIKI WITH OTHER STOCK

ABOUT AIkido Pharma

AIkido Pharma Inc.

United States

59 years

1978

5

PROFIT X PRICE AIKI

Financial Results AIKI

AIKI cash flow

Asset, Revenue and Profit Growth - AIKI

AIKI balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions